Therefore, given the pivotal role of TLR3-induced ROS generation and downstream inflammatory responses in corneal epithelium injury post virus infection, therapeutics targeting this important step may benefit in efficiently attenuating HSK progression. This evidence concerns the gene TLR3 and viral infectious disease.